865869-24-5

Usage

Uses

Used in Pharmaceutical Industry:
4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate is used as a protecting group for alcohols and phenols in the synthesis of complex organic molecules, facilitating the development of new pharmaceutical compounds.
Used in Agrochemical Industry:
In the agrochemical industry, 4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate serves as a protecting group in the synthesis of complex organic molecules, contributing to the development of new agrochemical products.
Used in Academic Research:
4-(tert-butyldimethylsilyloxy)cyclohex-1-enyl trifluoromethanesulfonate is utilized as a protecting group in the synthesis of complex organic molecules for academic research, enabling the exploration of new chemical reactions and the development of innovative synthetic methods.

Upstream product

• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 
• 55145-45-4 4-(tert-butyldimethylsilyloxy)cyclohexanone 
• 145100-51-2 N-(5-chloropyridin-2-yl)-1,1,1-trifluoro-N-[(trifluoromethyl)sulphonyl]methanesulphonamide 
• 1025373-45-8 trifluoromethanesulfonic acid anhydride 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 22428-87-1 4,4-ethylenedioxycyclohexan-1-ol 
• 112906-39-5 8-[(tert-butyldimethylsilyl)oxy]-1,4-dioxaspiro[4,5]decane 

Downstream Products

• 1227177-64-1 4-(2-fluoropyridin-3-yl)cyclohex-3-enol 
• 1350445-23-6 [2-fluoro-4-(4-hydroxy-cyclohex-1-enyl)-phenyl]-carbamic acid benzyl ester 
• 1350445-24-7 methanesulfonic acid 4-(4-benzyloxycarbonylamino-3-fluoro-phenyl)-cyclohex-3-enyl ester 
• 1350445-25-8 {4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohexyl]-2-fluoro-phenyl}-carbamic acid benzyl ester 
• 1350445-26-9 4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohexyl]-2-fluoro-phenylamine 
• 1350445-29-2 2-{4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohexyl]-2-fluoro-phenyl}-1-oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid tert-butyl ester 
• 1350445-33-8 2-[2-fluoro-4-(4-hydroxy-cyclohexyl)-phenyl]-1-oxo-2,8-diaza-spiro[4.5]decane-8-carboxylic acid tert-butyl ester 
• 1350444-85-7 {2-fluoro-4-[4-((S)-2-methyl-pyrrolidin-1-yl)-cyclohex-1-enyl]-phenyl}-carbamic acid benzyl ester 
• 1350445-16-7 {4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohex-1-enyl]-phenyl}-carbamic acid benzylester 
• 1350445-22-5 {4-[4-(tert-butyl-dimethyl-silanyloxy)-cyclohex-1-enyl]-2-fluoro-phenyl}-carbamic acidbenzyl ester 
• 1449115-31-4 6-((tert-butyldimethylsilyl)oxy)-1-tosyl-1H-indole 
• 1449115-37-0 4-(4-((tert-butyldimethylsilyl)oxy)cyclohex-1-en-1-yl)-1-tosyl-1H-1,2,3-triazole 
• 1449115-47-2 tert-butyl((4-ethynylcyclohex-3-en-1-yl)oxy)dimethylsilane 

Relevant academic research and scientific papers

Electrochemical Synthesis of (Aza)indolines via Dehydrogenative [3+2] Annulation: Application to Total Synthesis of (±)-Hinckdentine A

An electrochemical synthesis of functionalized (aza)indolines through dehydrogenative [3+2] annulation of arylamines with tethered alkenes has been developed. Previous reported syntheses through similar inter- and intramolecular annulation reactions requi

SUBSTITUTED PHENYL CYCLOALKYL PYRROLIDINE (PIPERIDINE) SPIROLACTAMS AND AMIDES, PREPARATION AND THERAPEUTIC USE THEREOF

The present invention discloses and claims respectively a series of substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides of formula (I) (Ia) and formula (Ib) as described herein. More specifically, the compounds of this invention

PYRAZINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS

Pyrazine compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS

Pyridine and pyrimidine compounds: or a pharmaceutically acceptable salt thereof, wherein m, n, R1, R2, R3, R4, R5, R6, R7, X1, X2, X3, X4, X5, X6, X7, X8, and Y are as defined in the specification; or a pharmaceutically acceptable salt thereof, wherein ring A, m, n, y, R2, R3, R4, R5, R6, R7, R8, R9, X1, X2, and ring A are as defined in the specification; and or a pharmaceutically acceptable salt thereof, wherein m, n, y, R2, R3, R4, R5, R6, R7, R9, X1, X2, and ring A are as defined in the specification; compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

COMPOUNDS AND METHODS FOR MODULATING FXR

Compounds of formula (I): formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and diseases related to dyslipidemia.

4-CARBOX PYRAZOLE DERIVATES USEFUL AS ANTI-VIRAL AGENTS

Novel antiviral compounds of Formula (I) : wherein: A represents hydroxy; R1 represents aryl, heteroaryl bonded through a ring carbon atom, or heterocyclyl bonded through a ring carbon atom, C1-6alkyl or -C5-9cycloalkyl, each of which may be optionally su

Enantioselective Diels-Alder cycloadditions with (SS)-2-(p- tolylsulfinyl)-1,4-naphthoquinone: Efficient kinetic resolution of chiral racemic vinylcyclohexenes

Chiral racemic vinylcyclohexenes 1a-m, bearing allylic and nonallylic oxygenated substituents on the cyclohexene ring, were submitted to Diels- Alder reactions with enantiomerically pure (SS)-(2-p-tolylsulfinyl)-1,4- naphthoquinone. The tandem cycloadditi